Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD)

Archives of Gerontology and Geriatrics

Volumn 55, Issue 2, 2012, Pages 257-260

  Yesil, Yusuf ^a   Kuyumcu, Mehmet Emin ^a   Cankurtaran, Mustafa ^a   Uz, Burak ^a   Kara, Atilla ^a   Kilic, Mustafa Kemal ^a   Halil, Meltem ^a   Ulger, Zekeriya ^a   Yavuz, Burcu Balam ^a   Haznedaroĝlu, Ibrahim C ^a   Ariogul, Servet ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Mean platelet volume; Vascular risk factors

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DSM-IV; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN PLATELET VOLUME; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD PLATELETS; CELL SIZE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PLATELET ACTIVATION; RISK; VASCULAR DISEASES;

MOROCCAN PEPPER VIRUS;

EID: 84864937280     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2011.09.016     Document Type: Article

References (30)

1. Bath P.M., Butterworth R.J. Platelet size: measurement, physiology and vascular disease. Blood Coagul. Fibrinolysis 1996, 7:157-161.
2. Bath P., Algert C., Chapman N., Neal B., Group P.C. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004, 35:622-626.
3. Bowles K.M., Cooke L.J., Richards E.M., Baglin T.P. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin. Lab. Haematol. 2005, 27:370-373.
4. Cameron H.A., Phillips R., Ibbotson R.M., Carson P.H. Platelet size in myocardial infarction. Br. Med. J. (Clin. Res. Ed.) 1983, 287:449-451.
5. Coban E., Ozdogan M., Yazicioglu G., Akcit F. The mean platelet volume in patients with obesity. Int. J. Clin. Pract. 2005, 59:981-982.
6. Debili N., Massé J.M., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the mega-karyocytic differentiation of CD34+ cells. Blood 1993, 82:84-95.
7. Dede D.S., Yavuz B., Yavuz B.B., Cankurtaran M., Halil M., Ulger Z., Cankurtaran E.S., Aytemir K., Kabakci G., Ariogul S. Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease?. J. Am. Geriatr. Soc. 2007, 55:1613-1617.
8. Dickstein D.L., Walsh J., Brautigam H., Stockton S.D., Gandy S., Hof P.R. Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt. Sinai J. Med. 2010, 77:82-102.
9. Endler G., Klimesch A., Sunder-Plassmann H., Schillinger M., Exner M., Mannhalter C., Jordanova N., Christ G., Thalhammer R., Huber K., Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br. J. Haematol. 2002, 117:399-404.
10. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
11. Frojmovic M.M., Milton J.G. Human platelet size, shape, and related functions in health and disease. Physiol. Rev. 1982, 62:185-261.
12. Greisenegger S., Endler G., Hsieh K., Tentschert S., Mannhalter C., Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?. Stroke 2004, 35:1688-1691.
13. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
14. Iwase E., Tawata M., Aida K., Ozaki Y., Kume S., Satoh K., Qi R., Onaya T. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism. 1998, 47:699-705.
15. Kishk Y.T., Trowbridge E.A., Martin J.F. Platelet volume subpopulations in acute myocardial infarction: an investigation of their homogeneity for smoking, infarct size and site. Clin. Sci. (Lond.) 1985, 68:419-425.
16. Kivipelto M., Helkala E.L., Laakso M.P., Hänninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Br. Med. J. 2001, 322:1447-1451.
17. Martin J.F., Trowbridge E.A., Salmon G., Plumb J. The biological signi-ficance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb. Res. 1983, 32:443-460.
18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
19. Querfurth H.W., LaFerla F.M. Alzheimer's disease. N. Engl. J. Med. 2010, 362:329-344.
20. Rabe-Jabłońska J., Bieńkiewicz W. Anxiety disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association: diagnostic and statistical manual of mental disorders (DMS-IV-options book). Psychiatr. Pol. 1994, 28:255-268. (in Polisah).
21. Sandhaus L.M., Meyer P. How useful are CBC and reticulocyte reports to clinicians?. Am. J. Clin. Pathol. 2002, 118:787-793.
22. Sharp D.S., Benowitz N.L., Bath P.M., Martin J.F., Beswick A.D., Elwood P.C. Cigarette smoking sensitizes and desensitizes impedance-measured ADP-induced platelet aggregation in whole blood. Thromb. Haemost. 1995, 74:730-735.
23. Sharpe P.C., Trinick T. Mean platelet volume in diabetes mellitus. Q. J. Med. 1993, 86:739-742.
24. Slavka G., Perkmann T., Haslacher H., Greisenegger S., Marsik C., Wagner O.F., Endler G. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1215-1218.
25. Stähelin H.B., Monsch A.U., Spiegel R. Early diagnosis of dementia via a two-step screening and diagnostic procedure. Int. Psychogeriatr. 1997, 9(Suppl. 1):123-130.
26. Tavil Y., Sen N., Yazici H.U., Hizal F., Abaci A., Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb. Res. 2007, 120:245-250.
27. Tohgi H., Suzuki H., Tamura K., Kimura B. Platelet volume, aggregation, and adenosine triphosphate release in cerebral thrombosis. Stroke 1991, 22:17-21.
28. Ukraintseva S., Sloan F., Arbeev K., Yashin A. Increasing rates of dementia at time of declining mortality from stroke. Stroke 2006, 37:1155-1159.
29. van Oijen M., de Jong F.J., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Atherosclerosis and risk for dementia. Ann. Neurol. 2007, 61:403-410.
30. Yavuz B.B., Yavuz B., Halil M., Cankurtaran M., Ulger Z., Cankurtaran E.S., Aytemir K., Ariogul S. Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's disease. Int. Psychogeriatr. 2008, 20:815-823.